Literature DB >> 18294253

Analysis of beta globin mutations in the Indian population: presence of rare and novel mutations and region-wise heterogeneity.

E S Edison1, R V Shaji, S G Devi, A Moses, A Viswabandhya, V Mathews, B George, A Srivastava, M Chandy.   

Abstract

Beta thalassaemia is a major public health problem in India. A comprehensive database of the spectrum of mutations causing beta thalassaemia in the Indian population is necessary. This study in which a large number of patients with beta thalassaemia including those from certain regions that were not explored earlier shows a great heterogeneity of mutations. Several novel and rare alleles that have not been reported earlier in the Indian population have been identified, and mutations differ in frequency in different regions of the country. This information on the spectrum of mutations has implications for the control of beta thalassaemia in a population with complex ethnic background and also on the genotype-phenotype correlation of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294253     DOI: 10.1111/j.1399-0004.2008.00973.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  12 in total

1.  Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes.

Authors:  S Sinha; M L Black; S Agarwal; R Colah; R Das; K Ryan; M Bellgard; A H Bittles
Journal:  Hugo J       Date:  2010-02-10

2.  Haemoglobinopathies in eastern Indian states: a demographic evaluation.

Authors:  Rachana Nagar; Sujata Sinha; Rajiva Raman
Journal:  J Community Genet       Date:  2014-07-25

3.  Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China.

Authors:  Jing He; Wenhui Song; Jinlong Yang; Sen Lu; Yuan Yuan; Junfu Guo; Jie Zhang; Kai Ye; Fan Yang; Fangfang Long; Zhiyu Peng; Haijing Yu; Le Cheng; Baosheng Zhu
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

Review 4.  Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India.

Authors:  R B Colah; A C Gorakshakar; A H Nadkarni
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

Review 5.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

6.  Genetic heterogeneity of the β-globin gene in various geographic populations of Yunnan in southwestern China.

Authors:  Jie Zhang; Jing He; Xiao-Hong Zeng; Shi-Jun Ge; Yu Huang; Jie Su; Xue-Mei Ding; Ji-Qing Yang; Yong-Jiu Cao; Hong Chen; Ying-Hong Zhang; Bao-Sheng Zhu
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Genetic Heterogeneity of Beta Globin Mutations among Asian-Indians and Importance in Genetic Counselling and Diagnosis.

Authors:  Ravindra Kumar; Kritanjali Singh; Inusha Panigrahi; Sarita Agarwal
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

8.  A Toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action.

Authors:  L C Nacul; A Stewart; C Alberg; S Chowdhury; M W Darlison; C Grollman; A Hall; B Modell; S Moorthie; G S Sagoo; H Burton
Journal:  J Public Health (Oxf)       Date:  2013-05-10       Impact factor: 2.341

9.  Profiling β Thalassemia Mutations in Consanguinity and Nonconsanguinity for Prenatal Screening and Awareness Programme.

Authors:  Ravindra Kumar; Vandana Arya; Sarita Agarwal
Journal:  Adv Hematol       Date:  2015-10-21

10.  Care-Related Quality of Life of Caregivers of Beta-Thalassemia Major Children: An Epidemiological Study in Eastern India.

Authors:  Bijit Biswas; Narendra Nath Naskar; Keya Basu; Aparajita Dasgupta; Rivu Basu; Bobby Paul
Journal:  J Epidemiol Glob Health       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.